Nick Daneman

1.3k total citations
7 papers, 11 citations indexed

About

Nick Daneman is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Clinical Biochemistry. According to data from OpenAlex, Nick Daneman has authored 7 papers receiving a total of 11 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Applied Microbiology and Biotechnology and 2 papers in Clinical Biochemistry. Recurrent topics in Nick Daneman's work include Antibiotic Use and Resistance (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Nick Daneman is often cited by papers focused on Antibiotic Use and Resistance (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Bacterial Identification and Susceptibility Testing (2 papers). Nick Daneman collaborates with scholars based in Canada, Australia and Switzerland. Nick Daneman's co-authors include Sameera Aljohani, Yaseen M. Arabi, Majid M. Alshamrani, Beate Sander, Samira Mubareka, Jennifer Grant, Adrienne K. Chan, Michael Fralick, Louis‐Patrick Haraoui and Robert Fowler and has published in prestigious journals such as JAMA, PLoS ONE and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Nick Daneman

5 papers receiving 11 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Daneman Canada 2 8 4 3 3 3 7 11
Edwin Shumba Tanzania 2 7 0.9× 2 0.5× 2 0.7× 3 1.0× 3 11
Lucien R Swetschinski United States 2 5 0.6× 1 0.3× 2 0.7× 2 0.7× 5 1.7× 3 10
Michele Fabiano Mariani Italy 2 4 0.5× 1 0.3× 3 1.0× 3 1.0× 4 1.3× 2 18
Authia P Gray Croatia 1 4 0.5× 2 0.7× 2 0.7× 4 1.3× 2 8
Emily G. McDonald Canada 2 4 0.5× 2 0.5× 3 1.0× 1 0.3× 1 0.3× 8 6
Maria Tereza Freitas Tenório Brazil 2 4 0.5× 3 0.8× 2 0.7× 5 5
Haftom Niguse Abraha Ethiopia 2 8 1.0× 2 0.7× 3 1.0× 2 13
P Díez Villanueva Spain 2 8 1.0× 2 0.5× 1 0.3× 2 0.7× 12 4.0× 4 24
S. Cabral Switzerland 2 4 0.5× 2 0.5× 1 0.3× 1 0.3× 5 1.7× 2 6
María Spencer Chile 2 4 0.5× 5 1.3× 2 0.7× 4 1.3× 4 9

Countries citing papers authored by Nick Daneman

Since Specialization
Citations

This map shows the geographic impact of Nick Daneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Daneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Daneman more than expected).

Fields of papers citing papers by Nick Daneman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Daneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Daneman. The network helps show where Nick Daneman may publish in the future.

Co-authorship network of co-authors of Nick Daneman

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Daneman. A scholar is included among the top collaborators of Nick Daneman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Daneman. Nick Daneman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ong, Sean Wei Xiang, Ruxandra Pinto, Asgar Rishu, et al.. (2025). Clinical course of patients with bloodstream infections enrolled in the BALANCE clinical trial. Journal of Antimicrobial Chemotherapy. 80(10). 2752–2758. 1 indexed citations
2.
Enshaei, Nastaran, Arash Mohammadi, Farnoosh Naderkhani, et al.. (2025). Differentiation of COVID-19 from other types of viral pneumonia and severity scoring on baseline chest radiographs: Comparison of deep learning with multi-reader evaluation. PLoS ONE. 20(7). e0328061–e0328061. 1 indexed citations
3.
Lee, Todd C., Connor Prosty, Michael Fralick, et al.. (2025). Seven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection. JAMA Network Open. 8(3). e251421–e251421. 4 indexed citations
4.
Zanichelli, Veronica, Jacqueline Wong, Zahra Sohani, et al.. (2025). P-225. Effect of isolating Clostridioides difficile asymptomatic carriers on the incidence of healthcare-associated C. difficile infections: a systematic review and meta-analysis. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
5.
Ong, Sean Wei Xiang, Nick Daneman, & Steven Y. C. Tong. (2025). Trials Within Trials—Optimizing the Delivery of RCTs. JAMA. 334(7). 578–578.
6.
Daneman, Nick & Rob Fowler. (2025). 376. 7 versus 14 days of Antibiotic Treatment for Patients with Bloodstream Infections. Open Forum Infectious Diseases. 12(Supplement_1).
7.
Arabi, Yaseen M., et al.. (2018). Duration of antibiotic therapy for critically ill patients with bloodstream infections: A retrospective observational in Saudi Arabia. Annals of Thoracic Medicine. 13(1). 63–63. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026